Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance. [electronic resource]
Producer: 20121119Description: 1579-86 p. digitalISSN:- 1432-0584
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bendamustine Hydrochloride
- Drug Tolerance
- Female
- Follow-Up Studies
- Frail Elderly
- Humans
- Lymphoma, B-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Nitrogen Mustard Compounds -- administration & dosage
- Rituximab
- Survival Rate -- trends
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.